FUNCTIONS, SLEEP, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH SCLERODERMA DURING COVID-19: CROSS - SECTIONAL STUDY
Türk Fizyoterapi ve Rehabilitasyon Dergisi · 31.08.2023 · 34 (2) · 182-188
DOI: 10.21653/tjpr.1105576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Türk Fizyoterapi ve Rehabilitasyon Dergisi, online erschienen am 31.08.2023. Verfasst von Tuğba ÇİVİ KARAASLAN und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Purpose
COVID-19, which has affected people in various ways, has also shown to cause various limitations on the lives of Scleroderma patients. The current study aims at evaluating the upper extremity functions, sleep quality, fatigue, and health-related quality of life in Scleroderma patients and to determine the factors affecting upper extremity functions.
Methods
A total of 83 participants were recruited in this study. Of the participants, 39 were Scleroderma patients (mean age 43.28±9.96 years) and 44 were healthy controls (mean age 40.05±8.89 years). The Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) and Michigan Hand Outcomes Questionnaire (MHQ) were applied to evaluate upper extremity functions of the participants. Pittsburgh Sleep Quality Index (PSQI), Fatigue Severity Scale (FSS), and the Scleroderma Health Assessment Questionnaire (SHAQ) were used to evaluate the sleep quality, fatigue, and health-related quality of life, respectively.
Results
Scleroderma patients had significantly lower scores in hand functions, sleep quality, fatigue, and health-related quality than the healthy group (p=0.001). The correlations between DASH and PSQI (r=0.559, p=0.001), FSS (r=0.496, p=0.001), SHAQ scores (r=0.754, p=0.001) were highly positive. Similarly, a high correlation was found between MHQ and SHAQ scores (r=-0.679, p=0.001).
Conclusion
Upper extremity functions and health-related quality of life were found to be affected in patients with Scleroderma. It was revealed that upper extremity functions were affected by sleep quality, fatigue, and health-related quality of life. Therefore, knowing all these effects and their relationships with each other allows to draw a systematic treatment plan on Scleroderma patients.
Zitieren
APA
KARAASLAN, T. Ç., TARAKCI, E., KELEŞ, Ö., KELEŞ, Y. A., & UĞURLU, S. (2023). FUNCTIONS, SLEEP, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH SCLERODERMA DURING COVID-19: CROSS - SECTIONAL STUDY. Türk Fizyoterapi ve Rehabilitasyon Dergisi, 34(2), 182-188. https://doi.org/10.21653/tjpr.1105576
Vancouver
KARAASLAN TÇ, TARAKCI E, KELEŞ Ö, KELEŞ YA, UĞURLU S. FUNCTIONS, SLEEP, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH SCLERODERMA DURING COVID-19: CROSS - SECTIONAL STUDY. Türk Fizyoterapi ve Rehabilitasyon Dergisi. 2023;34(2):182-188. doi:10.21653/tjpr.1105576
BibTeX
@article{KARAASLAN2023,
author = {KARAASLAN, Tuğba ÇİVİ and TARAKCI, Ela and KELEŞ, Özal and KELEŞ, Yasemin ASLAN and UĞURLU, Serdal},
title = {FUNCTIONS, SLEEP, FATIGUE AND QUALITY OF LIFE IN PATIENTS WITH SCLERODERMA DURING COVID-19: CROSS - SECTIONAL STUDY},
journal = {Türk Fizyoterapi ve Rehabilitasyon Dergisi},
year = {2023},
volume = {34},
number = {2},
pages = {182--188},
doi = {10.21653/tjpr.1105576}
}
EUVIMED